Coupler Enterprises

FDA inspection history across 2 sites, 2020 to 2023

1
Form 483
1
Close-out
1
Warning letter

Every document, by year

  • Form 483
  • Close-out
  • Warning letter

2020: one close-out letter and one warning letter; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2020One close-out letter and one warning letter, at Warrington, Pennsylvania.
  2. 2023One Form 483, at Horsham, Pennsylvania.

Cited most

Across all Coupler Enterprises observations on file

The complete Coupler Enterprises file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2023-08-10483 Form 483$99
2020-09-15Close-out Close-out letter$99
2020-09-15Warning letter Warning letter$99

Investigators on these documents

Brandy N. Lepage (1)

FEI number 3003734940 · most recent document Aug 10, 2023

About Coupler Enterprises

How many FDA Form 483s has Coupler Enterprises received?

FDA Intel has 1 Form 483 on file for Coupler Enterprises; the most recent is dated Aug 10, 2023.

When was Coupler Enterprises last inspected by FDA?

The most recent FDA inspection document on file for Coupler Enterprises is a Form 483 dated Aug 10, 2023, for the site in Horsham, Pennsylvania.

What did FDA cite at Coupler Enterprises?

The regulations cited most in the observations on file for Coupler Enterprises are 21 CFR 211.122(g)(3) (Materials examination and usage criteria), 1 time; 21 CFR 211.130(e) (Packaging and labeling operations), 1 time; 21 CFR 211.170(b) (Reserve samples), 1 time.

Has Coupler Enterprises received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Coupler Enterprises; the most recent is dated Sep 15, 2020.